Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Second-Chance Placement of Hemodialysis Patients After Involuntary Discharge for Disruptive Behavior 2019
2019 Description of 5 Novel SLC34A3/NPT2c Mutations Causing Hereditary Hypophosphatemic Rickets With Hypercalciuria 2019
2019 Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease 2019
2019 Rituximab or cyclosporine in the treatment of membranous nephropathy 2019
2019 Health-related quality of life in glomerular disease 2019
2019 A novel fluorescent clinical method to rapidly quantify plasma volume 2019
2019 Confidence in Women's Health: A Cross Border Survey of Adult Nephrologists. 2019
2019 CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease 2019
2019 Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1 2019
2019 Renal Complications in Pregnancy Preceding Glomerulonephropathy Diagnosis 2019
2019 The emerging role of complement proteins as a target for therapy of IgA nephropathy 2019
2018 Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study 2018
2018 Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes 2018
2018 Secondary IgA nephropathy 2018
2018 Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients 2018
2018 A novel method for rapid bedside measurement of GFR 2018
2018 Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy 2018
2017 Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation 2017
2016 The origin and activities of IgA1-containing immune complexes in IGA nephropathy 2016
2015 Migrated intra-jejunal peritoneal dialysis catheter 2015
2015 Oral anticoagulants and risk of nephropathy 2015
2015 New Insights into the Pathogenesis of IgA Nephropathy. 2015
2015 Screening for Coronary Artery Disease in Kidney Transplant Candidates 2015
2015 A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR) 2015
2015 Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial 2015
2015 The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial 2015
2014 Dietary patterns and risk of death and progression to ESRD in individuals with CKD: A cohort study 2014
2014 The interdisciplinary team: The whole is larger than the parts 2014
2013 Renovascular hypertension associated with pseudoaneurysm following blunt trauma 2013
2013 Bullous Lesions After Use of a Commercial Therapeutic Hypothermia Temperature Management System: A Possible Burn Injury? 2013
2013 Association between urinary albumin excretion and coronary heart disease in black vs white adults 2013
2013 Cardiovascular risk factors in CKD associate with both ESRD and mortality 2013
2013 Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: The REasons for geographic and racial differences in stroke (REGARDS) study 2013
2013 Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: The REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study 2013
2013 Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease 2013
2012 Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 2012
2012 Racial differences in albuminuria, kidney function, and risk of stroke 2012
2012 Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease 2012
2012 Kidney disease education one year after the medicare improvement of patients and providers act: A survey of US nephrology practices 2012
2011 Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality 2011
2011 Warfarin-related nephropathy: Another newly recognized complication of an old drug 2011
2009 Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis 2009
2008 Gadolinium nephrotoxicity: Case report of a rare entity and review of the literature 2008
2008 Gadolinium nephrotoxicity: case report of a rare entity and review of the literature. 2008
2008 Treatment of autosomal dominant polycystic kidney disease (ADPKD): The new horizon for children with ADPKD 2008
2004 Medullary cystic kidney disease type 2 [1] (multiple letters) 2004
2003 Cystic and Inherited Kidney Diseases 2003

Chapter

Year Title Altmetric
2013 Polycystic and other cystic kidney diseases.  362-370. 2013

Research Overview

  • IgA nephropathy
    Glomerulonephritis
    ADPKD
  • Principal Investigator On

  • Private Grant  awarded by CALLIDITAS THERAPEUTICS AB 2019 - 2026
  • Private Grant  awarded by REATA PHARMACEUTICALS 2019 - 2024
  • Private Grant  awarded by RETROPHIN, INC. 2019 - 2024
  • Private Grant  awarded by ACHILLION PHARMACEUTICALS INC 2018 - 2022
  • Private Grant  awarded by REATA PHARMACEUTICALS 2019 - 2021
  • Private Grant  awarded by REATA PHARMACEUTICALS 2017 - 2021
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2019 - 2021
  • Private Grant  awarded by REATA PHARMACEUTICALS 2018 - 2019
  • Private Grant  awarded by ABBVIE INC 2015 - 2018
  • A Randomized Controlled Trial of Rituximub versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)  awarded by MAYO CLINIC 2013 - 2018
  • Private Grant  awarded by FAST BIOMEDICAL 2017
  • Private Grant  awarded by NEPHROGENEX, INC. 2015 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2015
  • Private Grant  awarded by FAST BIOMEDICAL 2013 - 2014
  • Private Grant  awarded by REATA PHARMACEUTICALS 2011 - 2013
  • Private Grant  awarded by REATA PHARMACEUTICALS 2012
  • Private Grant  awarded by AMGEN, INC. 2007 - 2012
  • Private Grant  awarded by REATA PHARMACEUTICALS 2009 - 2010
  • Investigator On

  • Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2020 - 2025
  • Center for Clinical and Translational Science (3 Linked Awards UL1, KL2, TL1)  awarded by National Center for Advancing Translational Sciences/NIH/DHHS 2019 - 2024
  • Molecular Basis of Pathogenicity of IgA1-Containing Immune Complexes  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2024
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research - Core A  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • Private Grant  awarded by IDORSIA PHARMACEUTICALS LTD 2019 - 2022
  • Private Grant  awarded by IDORSIA PHARMACEUTICALS LTD 2018 - 2021
  • Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) IV: Prognosis for End-Stage Renal Disease and Biomarker Validation  awarded by UNIVERSITY OF KANSAS (MEDICAL CENTER) 2017 - 2021
  • Cure GN 2.0 - UNC-PCC  awarded by University of North Carolina at Chapel Hill 2019 - 2020
  • GDCN Clinical Center - Advancing Clinical Research in Primary Glomerular Diseases  awarded by University of North Carolina at Chapel Hill 2014 - 2019
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2015 - 2018
  • Cellular Bioenergetics as a Predictor of Diabetic Nephropathy  awarded by GEORGIA REGENTS UNIVERSITY (AUGUSTA) 2013 - 2015
  • Private Grant  awarded by Genzyme Corporation 2013 - 2015
  • Private Grant  awarded by Bayer HealthCare 2013 - 2014
  • Private Grant  awarded by QUESTCOR PHARMACEUTICALS, INC. 2011 - 2014
  • Private Grant  awarded by AMICUS THERAPEUTICS, INC 2011 - 2013
  • Education And Training

  • Doctor of Medicine, American University of Beirut 1997
  • St. Louis University Hospitals, Internship 1999
  • American University of Beirut Medical Center, Internship 1998
  • Emory University Hospital Systems, Residency 2001
  • St. Louis University Hospitals, Residency 2000
  • Emory University Hospital Systems, Postdoctoral Fellowship 2005
  • Full Name

  • Dana Rizk